{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:36:07Z","timestamp":1790760967440,"version":"4.1.0"},"reference-count":34,"publisher":"Impact Journals, LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,1,24]]},"DOI":"10.18632\/oncotarget.14130","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T19:26:48Z","timestamp":1482866808000},"page":"6483-6495","source":"Crossref","is-referenced-by-count":44,"title":["Recurrent genetic defects on chromosome 5q in myeloid neoplasms"],"prefix":"10.18632","volume":"8","author":[{"given":"Naoko","family":"Hosono","sequence":"first","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"},{"name":"First Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Makishima","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reda","family":"Mahfouz","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartlomiej","family":"Przychodzen","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"},{"name":"Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Jerez","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"LaFramboise","sequence":"additional","affiliation":[{"name":"Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantana","family":"Polprasert","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Clemente","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Shiraishi","sequence":"additional","affiliation":[{"name":"Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Chiba","sequence":"additional","affiliation":[{"name":"Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Laboratory of Sequence Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Miyano","sequence":"additional","affiliation":[{"name":"Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan"},{"name":"Laboratory of Sequence Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Sanada","sequence":"additional","affiliation":[{"name":"Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"},{"name":"Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit K.","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Oncology, Albert Einstein College of Medicine, Bronx, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"McDevitt","sequence":"additional","affiliation":[{"name":"Division of Hematology and Hematological Malignancy, Department of Internal Medicine and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan F.","family":"List","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogen","family":"Saunthararajah","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkael A.","family":"Sekeres","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"},{"name":"Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"},{"name":"LLR Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Boultwood","sequence":"additional","affiliation":[{"name":"LLR Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"},{"name":"Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw P.","family":"Maciejewski","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"},{"name":"Leukemia Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,12,23]]},"reference":[{"key":"1","first-page":"346","article-title":"Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Espanol de Citogenetica Hematologica","volume":"10","author":"Marques","year":"2000","journal-title":"Br J Haematol"},{"key":"2","first-page":"4638","article-title":"Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome","volume":"9","author":"Wainscoat","year":"2002","journal-title":"Blood"},{"key":"3","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/leu.2010.20","article-title":"Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia","volume":"2","author":"Killick","year":"2010","journal-title":"Leukemia"},{"key":"4","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1182\/blood-2010-04-273771","article-title":"Advances in the 5q- syndrome","volume":"11","author":"Wainscoat","year":"2010","journal-title":"Blood"},{"key":"5","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1200\/JCO.2011.36.1824","article-title":"Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited","volume":"3","author":"Maciejewski","year":"2012","journal-title":"J Clin Oncol"},{"key":"6","first-page":"1312","article-title":"Medical Research Council Adult Leukemia Working P. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial","volume":"9","author":"Goldstone","year":"2001","journal-title":"Blood"},{"key":"7","first-page":"4075","article-title":"Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group\/Eastern Cooperative Oncology Group Study","volume":"9","author":"Appelbaum","year":"2000","journal-title":"Blood"},{"key":"8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1182\/blood-2002-11-3343","article-title":"Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series","volume":"10","author":"Larson","year":"2003","journal-title":"Blood"},{"key":"9","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/leu.2010.105","article-title":"WHO-defined \u2018myelodysplastic syndrome with isolated del(5q)\u2019 in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations","volume":"2","author":"Tefferi","year":"2010","journal-title":"Leukemia"},{"key":"10","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1200\/JCO.2005.03.6715","article-title":"Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q","volume":"2","author":"Nimer","year":"2006","journal-title":"J Clin Oncol"},{"key":"11","first-page":"2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties","volume":"9","author":"Goldstone","year":"1998","journal-title":"Blood"},{"key":"12","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","article-title":"Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)","volume":"10","author":"Stone","year":"2002","journal-title":"Blood"},{"key":"13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1006\/geno.2000.6414","article-title":"Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q)","volume":"7","author":"Le Beau","year":"2001","journal-title":"Genomics"},{"key":"14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature06494","article-title":"Identification of RPS14 as a 5q- syndrome gene by RNA interference screen","volume":"45","author":"Golub","year":"2008","journal-title":"Nature"},{"key":"15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nm.2054","article-title":"Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype","volume":"1","author":"Humphries","year":"2010","journal-title":"Nat Med"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.08.001","article-title":"Role of Casein Kinase 1A1 in the Biology and Targeted Therapy of del(5q) MDS","author":"Ebert","year":"2014","journal-title":"Cancer Cell"},{"key":"17","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/leu.2010.31","article-title":"Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells","volume":"2","author":"Boultwood","year":"2010","journal-title":"Leukemia"},{"key":"18","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1038\/leu.2013.179","article-title":"Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies","volume":"2","author":"Moliterno","year":"2013","journal-title":"Leukemia"},{"key":"19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/leu.2009.189","article-title":"TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p","volume":"2","author":"Maciejewski","year":"2010","journal-title":"Leukemia"},{"key":"20","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1200\/JCO.2010.31.8576","article-title":"TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression","volume":"2","author":"Mufti","year":"2011","journal-title":"J Clin Oncol"},{"key":"21","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/bjh.12203","article-title":"TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis","volume":"16","author":"Mufti","year":"2013","journal-title":"Br J Haematol"},{"key":"22","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"12","author":"Forbes","year":"2013","journal-title":"Blood"},{"key":"23","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1056\/NEJMoa0912228","article-title":"Persistent malignant stem cells in del(5q) myelodysplasia in remission","volume":"36","author":"Ryden","year":"2010","journal-title":"N Engl J Med"},{"key":"24","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1172\/JCI74747","article-title":"Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria","volume":"12","author":"Makishima","year":"2014","journal-title":"J Clin Invest"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Heuser, Meggendorfer, Cruz, Fabisch, Klesse, Kohler, Gohring, Ganster, Shirneshan, Gutermuth, Cerny-Reiterer, Kronke, Panagiota, et al. Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q. Leukemia. [pii]https:\/\/doi.org\/10.1038\/leu.2015.49.","DOI":"10.1038\/leu.2015.49"},{"key":"26","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1038\/sj.onc.1204553","article-title":"Ras-GAP SH3 domain binding protein (G3BP) is a modulator of USP10, a novel human ubiquitin specific protease","volume":"2","author":"Draetta","year":"2001","journal-title":"Oncogene"},{"key":"27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nm1512","article-title":"Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation","volume":"1","author":"Clarke","year":"2007","journal-title":"Nat Med"},{"key":"28","doi-asserted-by":"publisher","first-page":"12974","DOI":"10.1073\/pnas.0811267106","article-title":"A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide","volume":"10","author":"Maciejewski","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"29","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1182\/blood-2007-01-068809","article-title":"Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders","volume":"11","author":"Le Beau","year":"2007","journal-title":"Blood"},{"key":"30","doi-asserted-by":"publisher","first-page":"11406","DOI":"10.1073\/pnas.0610477104","article-title":"Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients","volume":"10","author":"Hellstrom-Lindberg","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"31","doi-asserted-by":"publisher","first-page":"8482","DOI":"10.1158\/0008-5472.CAN-09-1153","article-title":"Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies","volume":"6","author":"Wang","year":"2009","journal-title":"Cancer Res"},{"key":"32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/leu.2010.231","article-title":"Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q","volume":"2","author":"Grau","year":"2011","journal-title":"Leukemia"},{"key":"33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/gcc.22151","article-title":"Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome","volume":"5","author":"Haferlach","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"34","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1182\/blood-2013-07-517953","article-title":"Haploinsufficiency of del(5q) genes, Egr1 and Apc, cooperate with Tp53 loss to induce acute myeloid leukemia in mice","volume":"12","author":"Le Beau","year":"2014","journal-title":"Blood"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T13:57:00Z","timestamp":1597672620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,23]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,1,24]]}},"alternative-id":["14130","28031539"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.14130","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,23]]}}}